Oral And Maxillofacial Specialist Pc. | |
7730 N Union Blvd Suite 103 Colorado Springs CO 80920-4084 | |
(719) 590-1500 | |
(719) 590-9379 |
Full Name | Oral And Maxillofacial Specialist Pc. |
---|---|
Speciality | Dentist |
Location | 7730 N Union Blvd, Colorado Springs, Colorado |
Authorized Official Name and Position | Ronald D Thoman (PRESIDENT) |
Authorized Official Contact | 7195901500 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Oral And Maxillofacial Specialist Pc. 7730 N Union Blvd Suite 103 Colorado Springs CO 80920-4084 Ph: (719) 590-1500 | Oral And Maxillofacial Specialist Pc. 7730 N Union Blvd Suite 103 Colorado Springs CO 80920-4084 Ph: (719) 590-1500 |
NPI Number | 1013922475 |
---|---|
Provider Enumeration Date | 07/31/2006 |
Last Update Date | 06/20/2008 |
Medicare PECOS PAC ID | 8527141936 |
---|---|
Medicare Enrollment ID | O20080208000083 |
News Archive
Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.
Future Science Group today announced the publication of a new article in Future Science OA examining the effects of diabetes on hospitalization risk, chances of multiple admissions, and length of hospitalization stay, for patients suffering from solid-organ malignancies such as breast, colorectal, lung and pancreas, among others.
Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.
What if there was a drug that could simultaneously curb a person's craving for alcohol while also protecting their heart and liver from alcohol's damaging effects?
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1013922475 | NPI | - | NPPES |
04019899 | Medicaid | CO | |
811466 | Other | MEDICARE ID-TYPE UNSPECIFIED |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223S0112X | Dentist - Oral And Maxillofacial Surgery | 6376 (Colorado) | Primary |
Provider Name | Ryan Hambleton |
---|---|
Provider Type | Practitioner - Oral Surgery |
Provider Identifiers | NPI Number: 1316267503 PECOS PAC ID: 3870809932 Enrollment ID: I20150903001856 |
News Archive
Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.
Future Science Group today announced the publication of a new article in Future Science OA examining the effects of diabetes on hospitalization risk, chances of multiple admissions, and length of hospitalization stay, for patients suffering from solid-organ malignancies such as breast, colorectal, lung and pancreas, among others.
Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.
What if there was a drug that could simultaneously curb a person's craving for alcohol while also protecting their heart and liver from alcohol's damaging effects?
› Verified 9 days ago
News Archive
Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.
Future Science Group today announced the publication of a new article in Future Science OA examining the effects of diabetes on hospitalization risk, chances of multiple admissions, and length of hospitalization stay, for patients suffering from solid-organ malignancies such as breast, colorectal, lung and pancreas, among others.
Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.
What if there was a drug that could simultaneously curb a person's craving for alcohol while also protecting their heart and liver from alcohol's damaging effects?
› Verified 9 days ago
Craig R. Parlet D.d.s. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1675 Briargate Blvd, Suite B, Colorado Springs, CO 80920 Phone: 719-528-6200 Fax: 719-534-9713 | |
Johnson Orthodontics Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 15435 Gleneagle Dr Ste 210, Colorado Springs, CO 80921 Phone: 719-572-5150 | |
My Local Colorado Dental Practice, Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3715 Bloomington St Unit 160, Colorado Springs, CO 80922 Phone: 719-599-0665 | |
Colorado Dental Professionals, Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 745 W Baptist Rd, Colorado Springs, CO 80921 Phone: 719-203-7375 | |
Co Specialty Dental Services Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 501 S Tejon St Ste 200, Colorado Springs, CO 80903 Phone: 719-596-3113 | |
Rand L. Redfern, Dds, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 669 Citadel Dr E, Colorado Springs, CO 80909 Phone: 719-599-9090 Fax: 719-573-9091 | |
Premier Dental Care Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 685 Citadel Dr E, Suite 302, Colorado Springs, CO 80909 Phone: 719-596-1011 Fax: 719-596-6748 |